• High purity, low endotoxin. Potassium sucrose heptasulfate / potassium sucrose octasulfate <0.1%.

• CDE registration number: F20210000349, US DMF under prepration.

• Better novel excipient for active drug loading in liposomes, Avoid hydrolysis and inactivation of irinotecan lactone ring, improve drug stability and prolong half-life.

SPECIFICATIONS OF SUCROSE OCTASULFATE POTASSIUM SALT CAS NO.: 73264-44-5

KEY BENEFITS OF SUCROSE OCTASULFATE POTASSIUM SALT

As a novel gradient drug-loading excipient in liposomes, it can stabilize drugs and improve drug encapsulation efficiency.

In fields of skincare, etc., it can improve skin water balance, inhibit microbial adhesion, stabilize growth factors, protect mucosal epithelium, reduce wound healing time, and have no local or systemic toxicity. It is mainly used to treat skin infections and injuries.

In the field of dentistry, potassium sucrose octasulfate can be used in topical preparations to prevent and treat diseases of teeth or tooth-supporting tissues.

SUCROSE OCTASULFATE POTASSIUM SALT PRODUCT PROPERTIES

Sucrose octasulfate potassium salt is widely used as a novel excipient.

High purity, low endotoxin.

Better novel excipient for active drug loading in liposome.

AVT, being one of the leading pharmaceutical excipients manufacturers, has been cultivating the market of high-end complex injection in China for more than ten years.

 AVT provides high-quality pharma excipients, such as excipients used in injections .

HAVE ANY QUESTIONS?

If you have any questions, please don't hesitate to contact us. We're always here to help with Pharmaceutical Excipients for your business. We can provide products ranging from grams to tons. AVT is able to produce and even register the product in US FDA according to your special needs.